FONR Market Analysis

Overview

Fundamentals

P/E ratio16.46Forward 10.88
EPS (TTM)$1.151.1% YoY
Profit margin7.1%HEALTHCARE
Market cap$119.3MMicro cap

Valuation

Forward P/E
10.88
PEG ratio
0.00
P/B
0.67
P/S (TTM)
1.13
EV/EBITDA
6.07

Profitability & growth

ROE (TTM)
6.0%
Operating margin
11.7%
Revenue growth YoY
2.4%
Dividend yield
Beta
0.99
Last earnings
Feb 16, 2026 · Reported $0.31
Analyst estimate. Actual results often differ.

Ratios are point-in-time. Historical metrics — no guarantees about what comes next.

News & Sentiment

Page 1 of 3 · 50 total

Via 3rd party. Not a recommendation or advice by The Balanced Investor Club. See disclaimer.

About Fonar Corporation

FONAR Corporation is engaged in the research, development, production, and marketing of Magnetic Resonance Imaging (MRI) scanners for the detection and diagnosis of human diseases in the United States. The company is headquartered in Melville, New York.

Classification

Exchange
NASDAQ
Country
USA
Currency
USD

Company profile

HQ
110 MARCUS DRIVE, MELVILLE, NY
Fiscal year end
June
Latest quarter
Dec 31, 2025
Market cap$119.3M
Shares outstanding$6.2M
52W high$18.95
52W low$12.14

Educational content · Not investment advice or recommendations

We're educators, not advisors. Your decisions are your own. Disclaimer